Clinical Trial Update: A Phase I Dose-escalation Trial of Definitive Single Dose Stereotactic Body Radiotherapy in Low-risk Breast Cancer Patients: DESERT I Trial [Phase 1]

View source ↗

Summary

A Phase I dose-escalation study assessing definitive single-dose stereotactic body radiotherapy in low-risk, early-stage breast cancer patients; the trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Universitat de les Illes Balears | Conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3), SBRT | Phase 1 | Status: ENROLLING_BY_INVITATION